Skip to main content

Eye Ointments Sold at Walmart, CVS Recalled Due to Infection Risk

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 27, 2024.

By Ernie Mundell HealthDay Reporter

TUESDAY, Feb. 27, 2024 -- Eye ointment products made in India and sold in the United States at Walmart, CVS and other retailers are being recalled due to a danger of infection.

Brassica Pharma Pvt. Ltd., of Maharastra, India, said it is recalling various eye lubricant products labeled Equate, CVS Health and AACE. Recalled products will have expiration dates ranging from February 2024 to September 2025.

"For those patients who use these products, there is a potential risk of eye infections or related harm. These products are intended to be sterile," the company said in a statement posted Monday by the U.S. Food and Drug Administration. "Ophthalmic drug products pose a potential heightened risk of harm to users because drugs applied to the eyes bypass some of the body’s natural defenses."

A full list of the recalled products, including photos, can be found here.

The recall comes on the heels of a large recall in 2023 of tainted eye drops tied to serious infections, vision loss and even deaths.

Brassica Pharma says that, so far, no reports of "adverse events" tied to the ointments have been reported.

"These products were distributed nationwide to wholesalers, retailers and via the product distributor, Walmart, CVS and AACE Pharmaceuticals Inc.," Brassica Pharma said.

"Consumers, distributors and retailers that have any product which is being recalled should cease distribution of the product," the company added. "Consumers should stop using the recalled eye ointment and may return any of the above listed products to the place of purchase."

For more information, consumers can reach the company at 833-225-9564 or info@brassicapharma.com.

Sources

  • Brassica Pharma, news release, Feb. 26, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted February 2024

Read this next

How to Predict Who Will Respond to Glaucoma Treatment -- and Who Won't

TUESDAY, July 16, 2024 -- An experimental blood test might be able to predict whether glaucoma patients will continue to lose their vision following treatment, researchers...

GLP-1 Drugs Ozempic, Wegovy Linked to Rare Blinding Condition

WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study warns. People with diabetes...

Protect Your Eyes From Summer's Dangers

SATURDAY, June 15, 2024 -- Summertime is primetime for the great outdoors, but that can mean new hazards for your eyes, one expert warned. Simple steps can help cut the risk...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.